News brief
On 2026-07-22, according to Xiniu Data, Yuanmazhiyao completed Pre-Series A financing, raising tens of millions of RMB. Investors were Yifeng Capital, Yingxi Intelligence and others. The company is a developer of circular mRNA-based in vivo CAR-T therapies.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年7月22日，据烯牛数据报道，元码智药完成Pre-A轮融资，金额数千万人民币。投资方为倚锋资本，英矽智能等。该公司为环状mRNA体内CAR‑T疗法研发商。